🔗 Share this article

This year's Nobel Prize in Physiology or Medicine has been granted for transformative findings that clarify how the immune system targets dangerous pathogens while protecting the healthy tissues.

Three esteemed researchers—Japan's Prof. Sakaguchi and US experts Mary Brunkow and Fred Ramsdell—received this accolade.

The research uncovered unique "sentinels" within the defense system that remove rogue immune cells that could attacking the body.

The discoveries are now paving the way for new therapies for autoimmune diseases and malignancies.

These winners will divide a monetary award worth 11 million Swedish kronor.

Crucial Discoveries

"The work has been essential for comprehending how the body's defenses operates and why we don't all develop serious self-attack conditions," commented the head of the Nobel Committee.

This team's studies explain a fundamental mystery: How does the defense system protect us from numerous infections while leaving our own tissues intact?

Our body's protection system employs immune cells that scan for signs of infection, even viruses and germs it has never encountered.

Such defenders utilize detectors—known as recognition units—that are generated by chance in a vast number of combinations.

This gives the defense network the capacity to combat a broad range of invaders, but the unpredictability of the process inevitably produces white blood cells that may target the body.

Security Guards of the Immune System

Researchers previously knew that some of these problematic defense cells were destroyed in the thymus—the site where white blood cells mature.

The latest Nobel Prize recognizes the identification of T-reg cells—known as the immune system's "security guards"—which travel through the system to disarm other immune cells that assault the healthy cells.

We know that this process fails in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

The prize committee added, "The findings have laid the foundation for a new field of investigation and spurred the creation of innovative therapies, for instance for tumors and immune disorders."

Regarding malignancies, regulatory T-cells block the body from attacking the tumor, so research are aimed at lowering their numbers.

In autoimmune diseases, experiments are exploring increasing regulatory T-cells so the organism is no longer being harmed. A comparable approach could also be useful in minimizing the chances of transplanted organ rejection.

Innovative Studies

Professor Sakaguchi, of Osaka University, conducted experiments on rodents that had their immune gland removed, leading to autoimmune disease.

The researcher demonstrated that introducing defense cells from other animals could prevent the illness—implying there was a system for preventing defenders from attacking the host.

Mary Brunkow, from the a research center in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in mice and humans that resulted in the identification of a gene critical for how T-regs operate.

"Their groundbreaking work has revealed how the body's defenses is controlled by T-reg cells, stopping it from accidentally targeting the healthy cells," commented a leading biological science specialist.

"This research is a striking example of how fundamental physiological research can have far-reaching consequences for public health."